JP2010501844A - アナライトの操作及び検出 - Google Patents
アナライトの操作及び検出 Download PDFInfo
- Publication number
- JP2010501844A JP2010501844A JP2009525096A JP2009525096A JP2010501844A JP 2010501844 A JP2010501844 A JP 2010501844A JP 2009525096 A JP2009525096 A JP 2009525096A JP 2009525096 A JP2009525096 A JP 2009525096A JP 2010501844 A JP2010501844 A JP 2010501844A
- Authority
- JP
- Japan
- Prior art keywords
- functional
- analyte
- particles
- conduit
- analytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 56
- 238000001514 detection method Methods 0.000 title claims description 33
- 238000000034 method Methods 0.000 claims abstract description 83
- 239000002245 particle Substances 0.000 claims abstract description 77
- 239000012530 fluid Substances 0.000 claims abstract description 27
- 238000000926 separation method Methods 0.000 claims abstract description 24
- 230000027455 binding Effects 0.000 claims abstract description 17
- 238000010168 coupling process Methods 0.000 claims abstract description 8
- 230000008878 coupling Effects 0.000 claims abstract description 7
- 238000005859 coupling reaction Methods 0.000 claims abstract description 7
- 239000011324 bead Substances 0.000 claims description 40
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 244000052769 pathogen Species 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 230000001717 pathogenic effect Effects 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 7
- 102000039446 nucleic acids Human genes 0.000 claims description 7
- 150000007523 nucleic acids Chemical class 0.000 claims description 7
- 229920001184 polypeptide Polymers 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 241000700605 Viruses Species 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 239000006249 magnetic particle Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 4
- 210000001124 body fluid Anatomy 0.000 claims description 4
- 239000010839 body fluid Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 108020004414 DNA Proteins 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 239000006166 lysate Substances 0.000 claims description 3
- 238000002493 microarray Methods 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 239000010836 blood and blood product Substances 0.000 claims description 2
- 229940125691 blood product Drugs 0.000 claims description 2
- 239000013592 cell lysate Substances 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 238000005086 pumping Methods 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 210000000605 viral structure Anatomy 0.000 claims 2
- 230000001413 cellular effect Effects 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 9
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 241000725303 Human immunodeficiency virus Species 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 238000005339 levitation Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 101001007348 Arachis hypogaea Galactose-binding lectin Proteins 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 241000223935 Cryptosporidium Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 108700008783 Hepatitis C virus E1 Proteins 0.000 description 1
- 241000709721 Hepatovirus A Species 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 101710125507 Integrase/recombinase Proteins 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000107 tumor biomarker Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dispersion Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- AIDS & HIV (AREA)
- Fluid Mechanics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0616508.8A GB0616508D0 (en) | 2006-08-18 | 2006-08-18 | Analyte manipulation and detection |
| PCT/GB2007/003142 WO2008020228A1 (en) | 2006-08-18 | 2007-08-17 | Analyte manipulation and detection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010501844A true JP2010501844A (ja) | 2010-01-21 |
| JP2010501844A5 JP2010501844A5 (enExample) | 2010-06-24 |
Family
ID=37081267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009525096A Pending JP2010501844A (ja) | 2006-08-18 | 2007-08-17 | アナライトの操作及び検出 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20100233675A1 (enExample) |
| EP (1) | EP2051809A1 (enExample) |
| JP (1) | JP2010501844A (enExample) |
| GB (1) | GB0616508D0 (enExample) |
| WO (1) | WO2008020228A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017504026A (ja) * | 2014-01-21 | 2017-02-02 | ステムセル テクノロジーズ インコーポレイテッド | 表面に結合した単一特異性四量体抗体複合体の組成物を使用して、試料から標的実体を分離する方法 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0701641D0 (en) * | 2007-01-29 | 2007-03-07 | Iti Scotland Ltd | Analyte manipulation and detection |
| JPWO2009123347A1 (ja) * | 2008-03-31 | 2011-07-28 | 日本たばこ産業株式会社 | ウイルス定量法 |
| GB0808089D0 (en) * | 2008-05-02 | 2008-06-11 | Iti Scotland Ltd | magnetic recognition system |
| CA2764678C (en) | 2009-06-04 | 2017-12-12 | Lockheed Martin Corporation | Multiple-sample microfluidic chip for dna analysis |
| US20110262989A1 (en) * | 2010-04-21 | 2011-10-27 | Nanomr, Inc. | Isolating a target analyte from a body fluid |
| CA2814720C (en) | 2010-10-15 | 2016-12-13 | Lockheed Martin Corporation | Micro fluidic optic design |
| US9322054B2 (en) | 2012-02-22 | 2016-04-26 | Lockheed Martin Corporation | Microfluidic cartridge |
| EP3288912A4 (en) | 2015-05-01 | 2018-11-07 | Biolegend, Inc. | Stable nanomagnetic particle dispersions |
| WO2017190117A1 (en) * | 2016-04-30 | 2017-11-02 | BioLegend, Inc. | Compositions and methods for performing magnetibuoyant separations |
| US10329554B2 (en) | 2016-11-07 | 2019-06-25 | Wavesense, Inc. | System and method for sequestering substances in bulk liquids |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002503334A (ja) * | 1996-09-04 | 2002-01-29 | テクニカル ユニバーシティ オブ デンマーク | 粒子の分離と分析用のマイクロフローシステム |
| JP2004503775A (ja) * | 2000-06-14 | 2004-02-05 | ボード・オブ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム | 検体混合物の組み合わせた磁気泳動および誘電泳動の操作のための方法および装置 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
| FR2804027B1 (fr) * | 2000-01-20 | 2002-08-30 | Monoclonal Antibodies Therapeu | Utilisation d'anticorps monoclonaux anti-ferritines dans le traitement de certains cancers |
| AU2000274922A1 (en) * | 2000-08-08 | 2002-02-18 | Aviva Biosciences Corporation | Methods for manipulating moieties in microfluidic systems |
| AU2001293232A1 (en) * | 2000-08-29 | 2002-03-13 | The Rockefeller University | Methods employing fluorescence quenching by metal surfaces |
| US6736978B1 (en) * | 2000-12-13 | 2004-05-18 | Iowa State University Research Foundation, Inc. | Method and apparatus for magnetoresistive monitoring of analytes in flow streams |
| EP1493014A2 (en) * | 2001-04-11 | 2005-01-05 | Burstein Technologies, Inc. | Multi-parameter assays including analysis discs and methods relating thereto |
| US7232691B2 (en) * | 2001-11-27 | 2007-06-19 | Los Alamos National Security, Llc | Bioassay and biomolecular identification, sorting, and collection methods using magnetic microspheres |
| US7105359B2 (en) * | 2002-11-12 | 2006-09-12 | Matsushita Electric Industrial Co., Ltd. | Specific coupling reaction measuring method and reagent kit and specific coupling reaction measuring apparatus for use in the same |
-
2006
- 2006-08-18 GB GBGB0616508.8A patent/GB0616508D0/en not_active Ceased
-
2007
- 2007-08-17 EP EP07789252A patent/EP2051809A1/en not_active Withdrawn
- 2007-08-17 WO PCT/GB2007/003142 patent/WO2008020228A1/en not_active Ceased
- 2007-08-17 US US12/438,003 patent/US20100233675A1/en not_active Abandoned
- 2007-08-17 JP JP2009525096A patent/JP2010501844A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002503334A (ja) * | 1996-09-04 | 2002-01-29 | テクニカル ユニバーシティ オブ デンマーク | 粒子の分離と分析用のマイクロフローシステム |
| JP2004503775A (ja) * | 2000-06-14 | 2004-02-05 | ボード・オブ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム | 検体混合物の組み合わせた磁気泳動および誘電泳動の操作のための方法および装置 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017504026A (ja) * | 2014-01-21 | 2017-02-02 | ステムセル テクノロジーズ インコーポレイテッド | 表面に結合した単一特異性四量体抗体複合体の組成物を使用して、試料から標的実体を分離する方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008020228A1 (en) | 2008-02-21 |
| US20100233675A1 (en) | 2010-09-16 |
| GB0616508D0 (en) | 2006-09-27 |
| EP2051809A1 (en) | 2009-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010501844A (ja) | アナライトの操作及び検出 | |
| JP2010517052A (ja) | アナライトの操作及び検出 | |
| US8697435B2 (en) | Integrated sample preparation and analyte detection | |
| US9086409B2 (en) | Immunoassay biochip | |
| JP6996502B2 (ja) | 標的分子の検出方法 | |
| JP6348553B2 (ja) | ＨＢｓ抗原を検出するための前処理用試薬キットおよびＨＢｓ抗原検出用試薬キット | |
| CN103575880B (zh) | 多组分标记免疫分析方法和即时检测系统 | |
| JP2010518046A (ja) | 病原体の結合 | |
| JP2010501844A5 (enExample) | ||
| JP2009510481A (ja) | 被分析物のマイクロ流体的検出 | |
| CN113528611A (zh) | 一种蛋白检测试剂盒及检测方法 | |
| JP5452217B2 (ja) | 試料中のｃ型肝炎ウイルスの有無を判定する方法、及びｃ型肝炎ウイルスの有無を判定するための試薬キット | |
| JP4879067B2 (ja) | 免疫測定用検体前処理液、免疫測定用試薬キット及び免疫測定方法 | |
| CN117343987A (zh) | 一种检测方法及试剂盒 | |
| JP7209498B2 (ja) | Ｂ型肝炎ウイルスコア抗体の免疫測定方法 | |
| WO2006129796A1 (ja) | 磁性粒子保持担体、およびその調製方法 | |
| Crestani et al. | Enhanced target-specific signal detection using an Escherichia coli lysate in multiplex microbead immunoassays with E. coli-derived recombinant antigens | |
| JP2012042456A (ja) | ターゲットの検出方法、バックグラウンド上昇抑制方法および検出装置 | |
| JP5844825B2 (ja) | 検出対象の検出及び定量のための方法及びキット | |
| US20110212432A1 (en) | Separation of blood cells from a blood sample | |
| EP3161485B1 (en) | Biosensor for the detection of target components in a sample | |
| WO2005119258A1 (ja) | 複数物質同時測定方法およびそれに使用する測定用デバイス | |
| CN113447657B (zh) | 一种检测抗乌头酸水合酶-IgG抗体的检测试剂盒 | |
| US20020019004A1 (en) | Method for isolating molecules, cells and other particles which are specifically bound to a large particle | |
| JP2003232793A (ja) | 高濃度磁性ビーズ固相迅速測定法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100430 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100430 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110811 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110816 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111114 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111121 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111215 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111222 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120105 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120113 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120501 |